Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
TCS IN THE NEWS
You have these already downloaded
We have sent you a copy of the report to your email again.
By SriJyothsna Yeleswarapu, Aditya Rao, Thomas Joseph, Vangala Govindakrishnan Saipradeep and Rajgopal Srinivasan, TCS
A research paper by TCS experts titled "A pipeline to extract drug-adverse event pairs from multiple data sources" was published in the reputed industry journal BMC Medical Informatics and Decision Making.
Pharmacovigilance aims to uncover and understand harmful side-effects of drugs, termed adverse events (AEs). Although the current process of pharmacovigilance is very systematic, the increasing amount of information available in specialized health-related websites as well as the exponential growth in medical literature presents a unique opportunity to supplement traditional adverse event gathering mechanisms with new-age ones.
The paper presents a semi-automated pipeline to extract associations between drugs and side effects from traditional structured adverse event databases as well as from non-traditional sources such as text from MEDLINE abstracts .
Read the complete paper here.